JMP Securities Downgrades Chelsea Therapeutics (CHTP) to Market Perform
Tweet
Share
E-mailGet Alerts CHTP Hot Sheet
Price: $6.52 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
JMP Securities downgraded Chelsea Therapeutics (NASDAQ: CHTP) from Market Outperform to Market Perform and removed its price target (prior $12.00).
For an analyst ratings summary and ratings history on Chelsea Therapeutics click here. For more ratings news on Chelsea Therapeutics click here.
Shares of Chelsea Therapeutics closed at $6.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- Citi Downgrades REA Group Ltd. (REA:AU) (RPGRY) to Neutral
- BofA Securities Downgrades Edison International (EIX) to Neutral, 'A once-in-a-generation reform opportunity falls short'
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
